Axcelis Technologies Inc (ACLS) · Nov 5, 2026 · Earnings
Beat — GAAP EPS $1.21 vs ~$1.11 consensus; Q4 revenue guide $275M vs ~$239M consensus
Axcelis earnings beat expectations and delivered a sharply higher Q4 revenue outlook, though margin compression and rising costs remain visible.
Axcelis is emerging from a semiconductor-equipment slowdown with memory demand recovering first, while Power and General Mature markets are only beginning to improve; its aftermarket CS&I business remains the steadier growth engine. Earlier 2026 planning called for overall revenue to be roughly flat, with memory growth offsetting weakness in Power and General Mature, while recent company commentary already pointed to improving demand and stronger 2027 momentum.
The quarter clearly beat the published bar. Revenue reached $237.8 million versus a published consensus near $230.1 million, while GAAP diluted EPS was $1.21 versus roughly $1.11 expected. The beat came alongside sequential systems growth and another CS&I revenue record. 〔0〕
| Q3 2026 | Q3 2025 | Consensus | |
|---|---|---|---|
| Revenue (Financial Highlights) | $237.8M (+11.3%) | $213.6M | ~$230.1M |
| GAAP diluted EPS (Financial Highlights) | $1.21 (+45.8%) | $0.83 | ~$1.11 |
| Non-GAAP diluted EPS (Non-GAAP reconciliation) | $1.26 (+4.1%) | $1.21 | |
| GAAP gross margin (Financial Highlights) | 41.0% (-60 bps) | 41.6% | |
| Non-GAAP operating margin (Non-GAAP reconciliation) | 16.6% (-160 bps) | 18.2% | |
| Adjusted EBITDA margin (Adjusted EBITDA reconciliation) | 18.5% (-170 bps) | 20.2% |
The more important surprise is the fourth-quarter outlook. Axcelis guided to approximately $275 million of revenue, well above the published consensus near $239 million, and non-GAAP EPS of $1.50 versus roughly $1.23 expected. That implies the recovery is arriving faster than the market had modeled, not merely that Axcelis eked out a quarterly beat.
The recovery is not yet translating cleanly into margins. Q3 revenue rose 11% year over year, but non-GAAP operating margin fell to 16.6% from 18.2%, and nine-month non-GAAP EPS declined to $3.04 from $3.38. Management attributed pressure on gross margin partly to foreign exchange, while transaction and integration costs tied to the Veeco merger remain material. 〔1〕
Cash generation and the balance sheet provide room to execute. Cash, cash equivalents and restricted cash ended the quarter at $201.4 million versus $195.1 million a year earlier, while nine-month operating cash flow was $76.7 million. The filing also shows the company carrying substantial investments and equity, giving it financial flexibility as it funds next-generation products and integrates the Veeco transaction. 〔2〕
Bottom line: This is more than a routine beat: the Q4 revenue outlook materially raises the near-term recovery signal and supports the memory-led rebound story. The caveat is that profitability still trails last year's margin profile, so the next test is whether stronger demand converts into durable operating leverage.
The published Q3 consensus was approximately $230.1 million of revenue and $1.11 of EPS, while published Q4 estimates were approximately $239.3 million of revenue and $1.23 of EPS.
Q4 earnings report, early 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!